Search research articles
Contact Us
Filters
Showing results (431-440 of 490) with videos related to
Page
of 49
Sort By:
Blood
|
October 1, 1991
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque
D C Matthews, F R Appelbaum, J F Eary, et al.
Blood
|
July 1, 1994
HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
A A Scott, D R Head, K J Kopecky, et al.
Bone Marrow Transplantation
|
September 1, 1991
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy
R H Van der Jagt, F R Appelbaum, F B Petersen, et al.
Blood
|
July 27, 1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study
C P Leith, K J Kopecky, I M Chen, et al.
Blood
|
August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
D C Matthews, F R Appelbaum, J F Eary, et al.
Blood
|
September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
P J Martin, S D Rowley, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 9, 2000
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation
R A Nash, R Kurzrock, J DiPersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
V A Morrison, K R Rai, B L Peterson, et al.
Leukemia
|
June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
R B Walter, B Gyurkocza, B E Storer, et al.
Leukemia
|
February 5, 2015
Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy
X Chen, L F Newell, H Xie, et al.
Page
of 49
Search research articles
Search
Showing results (431-440 of 490) with videos related to
Sort By:
Page
of 49
Blood
|
October 1, 1991
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque
D C Matthews, F R Appelbaum, J F Eary, et al.
Blood
|
July 1, 1994
HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
A A Scott, D R Head, K J Kopecky, et al.
Bone Marrow Transplantation
|
September 1, 1991
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy
R H Van der Jagt, F R Appelbaum, F B Petersen, et al.
Blood
|
July 27, 1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study
C P Leith, K J Kopecky, I M Chen, et al.
Blood
|
August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
D C Matthews, F R Appelbaum, J F Eary, et al.
Blood
|
September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
P J Martin, S D Rowley, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 9, 2000
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation
R A Nash, R Kurzrock, J DiPersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
V A Morrison, K R Rai, B L Peterson, et al.
Leukemia
|
June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
R B Walter, B Gyurkocza, B E Storer, et al.
Leukemia
|
February 5, 2015
Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy
X Chen, L F Newell, H Xie, et al.
Page
of 49